Table 3B. Grade 3 and 4 toxicities attributed to aflibercept and temozolomide for Arm 2.
Adverse Event | Aflibercept DL0 | Aflibercept DL1 | Temozolomide (DL0) | Temozolomide (DL1) |
---|---|---|---|---|
Biliary anastomotic leak | 1 | |||
Aspartate aminotransferase increase | 1 | |||
Cholecystitis | 1 | 1 | ||
Diarrhea | 1 | |||
Fatigue | 1 | 1 | ||
Dysphasia | 1 | |||
Hypertension | 5 | 2 | ||
Hyponatremia | 1 | 1 | ||
Palmar-plantar erythrodysesthesia syndrome | 1 | |||
Thromboembolic event | 1 | |||
Leukopenia | 2 | 2 | ||
Lymphopenia | 4 | 4 | ||
Neutropenia | 2 | 1 | 2 | |
Thrombocytopenia | 2 | 3 |